1. Home
  2. ABUS vs MOMO Comparison

ABUS vs MOMO Comparison

Compare ABUS & MOMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbutus Biopharma Corporation

ABUS

Arbutus Biopharma Corporation

HOLD

Current Price

$4.73

Market Cap

839.5M

Sector

Health Care

ML Signal

HOLD

Logo Hello Group Inc.

MOMO

Hello Group Inc.

HOLD

Current Price

$5.96

Market Cap

926.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABUS
MOMO
Founded
2005
2011
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
839.5M
926.4M
IPO Year
2008
2014

Fundamental Metrics

Financial Performance
Metric
ABUS
MOMO
Price
$4.73
$5.96
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
2.3M
969.5K
Earning Date
05-14-2026
06-04-2026
Dividend Yield
N/A
4.61%
EPS Growth
55.26
N/A
EPS
0.87
N/A
Revenue
$14,083,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$239.71
$3.68
P/E Ratio
$5.52
$10.60
Revenue Growth
128.21
N/A
52 Week Low
$3.08
$5.32
52 Week High
$5.10
$9.22

Technical Indicators

Market Signals
Indicator
ABUS
MOMO
Relative Strength Index (RSI) 64.91 58.43
Support Level $4.15 $5.73
Resistance Level $4.85 $6.52
Average True Range (ATR) 0.18 0.16
MACD 0.05 0.06
Stochastic Oscillator 85.54 98.51

Price Performance

Historical Comparison
ABUS
MOMO

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes imdusiran (AB-729), a GalNAc-conjugated, subcutaneously delivered ribonucleic acid interference (RNAi) therapeutic, and AB-101, its proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

About MOMO Hello Group Inc.

Hello Group Inc is a foremost player in Asia's online social networking space. Through Momo, Tantan and other properties within its product portfolio, It enable users to discover new relationships, expand their social connections and build meaningful interactions. Momo is a mobile application that connects people and facilitates social interactions based on location, interests and a variety of online recreational activities. Tantan, which it added to its family of applications through acquisition. Tantan is designed to help its users find and establish romantic connections as well as meet interesting people. The Group determined that it operated in three operating segments namely Momo, Tantan and QOOL. The majority of revenue comes from Chinese mainland as compare to Overseas.

Share on Social Networks: